NCT04467333 Giessen Pulmonary Hypertension in Lung Cancer Registry
| NCT ID | NCT04467333 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Giessen |
| Condition | Pulmonary Hypertension Due to Lung Diseases and Hypoxia |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2020-06-29 |
| Primary Completion | 2026-01-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2020-06-29 with a primary completion date of 2026-01-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.
Eligibility Criteria
Inclusion Criteria: * Patient with lung cancer at the University of Giessen lung Cancer Center. Exclusion Criteria: \-
Contact & Investigator
Bastian Eul, MD
PRINCIPAL INVESTIGATOR
JLU Giessen
Frequently Asked Questions
Who can join the NCT04467333 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Hypertension Due to Lung Diseases and Hypoxia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04467333 currently recruiting?
Yes, NCT04467333 is actively recruiting participants. Contact the research team at bastian.eul@innere.med.uni-giessen.de for enrollment information.
Where is the NCT04467333 trial being conducted?
This trial is being conducted at Giessen, Germany.
Who is sponsoring the NCT04467333 clinical trial?
NCT04467333 is sponsored by University of Giessen. The principal investigator is Bastian Eul, MD at JLU Giessen. The trial plans to enroll 500 participants.